AMN Healthcare Services (AMN) Bank of America Global Healthcare Conference 2026 summary
Event summary combining transcript, slides, and related documents.
Bank of America Global Healthcare Conference 2026 summary
14 May, 2026Industry trends and demand stabilization
Total addressable market surged from $24B pre-pandemic to $70B during COVID, now stabilizing at $34–35B with steady growth since.
Demand and bill rates have stabilized, with contract spend and utilization metrics steady for several quarters.
Many clients are at or below pre-COVID contract utilization rates, with some shifting back to flexible workforce strategies for cost-effectiveness.
Emotional overhang from pandemic-era contract spend is dissipating, with focus shifting to sustainable, multi-faceted workforce solutions.
Technology and predictive analytics are being leveraged to optimize staffing and reduce costs.
Business performance and growth outlook
Several business lines, including Allied, Schools, and Search, returned to year-over-year growth in Q1; Travel Nurse is near growth, driven by international demand.
Interim and Locums businesses are expected to return to growth by early 2027, with VMS and Language Services following a similar timeline.
Long-term plan targets mid-single digit top-line growth and double-digit EBITDA growth, with all business lines expected to be on a positive trajectory by late 2027.
EBITDA margins are expected to improve gradually, driven by operating leverage and strategic investments in higher-margin services and AI.
Q1 demonstrated strong platform leverage, especially during strike-related demand spikes.
Competitive landscape and market share
Market remains fragmented but is seeing increased consolidation, with some mid-sized players merging.
Maintained or grown market share in most business lines, focusing on winning new clients, expanding services, and increasing fill rates.
Significant opportunity remains to cross-sell 20 solutions to over 2,000 healthcare organizations.
Latest events from AMN Healthcare Services
- Tech-driven talent solutions and strong financials position for sustained growth and industry leadership.AMN
Investor presentation14 May 2026 - Revenue surged 100% year-over-year, led by labor disruption and travel nurse demand.AMN
Q1 202611 May 2026 - All board proposals passed; shareholder call for an independent chairman was rejected.AMN
AGM 20261 May 2026 - Q4 2025 revenue hit $748M, with Q1 2026 outlook projecting up to $1.24B on labor disruption.AMN
Q4 202511 Apr 2026 - Proxy seeks approval of director slate, executive pay, auditor, equity plan, and rejects board chair proposal.AMN
Proxy Filing18 Mar 2026 - Virtual annual meeting set for May 1, 2026, with online voting available until April 30.AMN
Proxy Filing18 Mar 2026 - Revenue and earnings declined sharply, but strong cash flow enabled significant debt reduction.AMN
Q2 20241 Feb 2026 - Q3 revenue beat expectations but fell 19% year-over-year; margin and demand pressures persist.AMN
Q3 202415 Jan 2026 - Q4 beat expectations, but a $222 million impairment led to a net loss and lower 2024 revenue.AMN
Q4 202411 Dec 2025